Capabilities
A World-Class API and FDF Manufacturer
Dedicated manufacturing operations were established in 1986 as Nanjing King-friend Biochemical Pharmaceutical Company (NKF).
Today NKF:
- Generates 15-20% of the global supply of Heparin
-
Produces prefilled syringes and vials in 2 facilities that are:
- State-of-the-art with fully integrated isolator systems
- Located in Nanjing and Chengdu, China
- U.S. FDA approved
- Employs more than 500 personnel, including 100 R&D experts
- Cytotoxic and non-cytotoxic
- Vial (liquid, lyophilized)
-
API plant
- Heparin and LMWH
-
FDF plant
- Prefilled syringe
- Vial (liquid, lyophilized)
Publically listed on Shanghai Stock Exchange with market capitalization of $3 billion U.S.
CRO/CMO partner to global pharmaceutical companies
Produces 100 million syringes and 70 million vials annually